These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1283534)

  • 41. Influences of electrical lesions of the dopaminergic system on morphine- and U-50,488H-induced analgesia in rats.
    Ohno M; Yamamoto T; Ueki S
    Pharmacol Biochem Behav; 1987 Jul; 27(3):457-61. PubMed ID: 3659068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of food intake by the kappa opioid U-50,488H: evidence for an effect on satiation.
    Badiani A; Rajabi H; Nencini P; Stewart J
    Behav Brain Res; 2001 Jan; 118(2):179-86. PubMed ID: 11164515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study.
    Spanagel R; Herz A; Shippenberg TS
    J Neurochem; 1990 Nov; 55(5):1734-40. PubMed ID: 1976759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
    Kalivas PW; Stanley D; Prange AJ
    Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal deprivation of neonatal rats produces enduring changes in dopamine function.
    Hall FS; Wilkinson LS; Humby T; Robbins TW
    Synapse; 1999 Apr; 32(1):37-43. PubMed ID: 10188636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Self-stimulation of the ventral tegmental area enhances dopamine release in the nucleus accumbens: a microdialysis study.
    Phillips AG; Coury A; Fiorino D; LePiane FG; Brown E; Fibiger HC
    Ann N Y Acad Sci; 1992 Jun; 654():199-206. PubMed ID: 1378709
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.
    O'Dell LE; Parsons LH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):711-9. PubMed ID: 15226384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage.
    Lillrank SM; Lipska BK; Kolachana BS; Weinberger DR
    J Neural Transm (Vienna); 1999; 106(2):183-96. PubMed ID: 10226938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of immunoneutralization of dynorphin1-17 and dynorphin1-8 on the activity of central dopaminergic neurons in the male rat.
    Manzanares J; Wagner EJ; Lookingland KJ; Moore KE
    Brain Res; 1992 Aug; 587(2):301-5. PubMed ID: 1356066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna ; Reddy PL; Bhargava HN
    Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Ichikawa J; Meltzer HY
    Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.